Board Committees

David W. Truetzel has approximately 20 years of experience in the financial services and technology industries in both a consultative and operating capacity. Mr. Truetzel is a General Partner of Augury Capital Partners, which he co-founded in 2006. He was a General Partner of Hela Capital Partners, a partnership focused on leveraged buyouts in the financial services industry, from 2001 through 2005. In addition, Mr. Truetzel was a Managing Director of Gryphon Investments II, a technology focused venture capital firm, from 2000 through 2003.. Mr. Truetzel sits on the Board of Directors of Enterprise Bank, Inc,  Elm Tree Funds II and Paranet, LLC.

Mr. Truetzel holds a B.S. in Accounting from Saint Louis University, an M.B.A. from The Wharton School and is a certified public accountant.

Eric A. Stookey currently serves as the Chief Operating Officer of OsteoRemedies®, Memphis, TN, where he has helped guide the medical device organization focused on infection remedies, since joining in 2015.  Prior to joining OsteoRemedies®, Mr. Stookey served as the President of the Extremities-Biologics division at Wright Medical Group, Inc. (Nasdaq:WMGI) through 2014.  He served in various other marketing and sales positions at Wright Medical Group, Inc. since 1995, including the Senior Vice President and Chief Commercial Officer, Vice President North American Sales, Senior Director of Sales – Central Region, and Director of Marketing for Large Joint Reconstruction Products. He also worked for DePuy Orthopedics, Inc. from 1993 to 1995.

Mr. Stookey earned his Masters of Business-Administration degree from Christian Brothers University and his Bachelor of Science degree in Business from the Indiana University School of Business. He previously served as an independent board member for Cartiva, Inc., Alpharetta, GA, until the successful acquisition of the business by Wright Medical Group, Inc in 2018.

Jeffrey White has operated in the surgical device and biomaterials industry for 35 years as a senior sales, marketing, business development and chief executive in Fortune 500, mid-size and start-up firms. Mr. White is currently Principal, Medtech Advisory Group LLC, a firm that advises early and mid-stage medtech firms. Most recently he was Vice President of Product Management at MiMedx, the leading placental allograft firm. Prior to that he was Global Director of Business Development for Synthes, a $4 billion global orthopedic firm that was acquired by Johnson and Johnson in 2012. Mr. White is a member of the AOSpine and ISASS spine societies.

Previously, Mr. White was founder or CEO and board member of three start-up device firms, most recently Applied Spine, now doing business as Rachiotek. Prior to his start-up experiences, he was Senior Director of Business Development and Marketing at US Surgical Corporation where he was instrumental in rapidly growing the firm from $300 million to $1 billion as the highly acquisitive leader in the minimally invasive surgery segment. Mr. White also served as Vice President and General Manager, Surgery at Richard Allan Medical.  As a business development and chief executive, Mr. White has executed more than 60 deals valued in excess of $ 1 billion.

Mr. White holds a B.S. cum laude in Biology from Union College in Schenectady, N.Y. and resides outside of Philadelphia, PA.

Jeffrey White has operated in the surgical device and biomaterials industry for 35 years as a senior sales, marketing, business development and chief executive in Fortune 500, mid-size and start-up firms. Mr. White is currently Principal, Medtech Advisory Group LLC, a firm that advises early and mid-stage medtech firms. Most recently he was Vice President of Product Management at MiMedx, the leading placental allograft firm. Prior to that he was Global Director of Business Development for Synthes, a $4 billion global orthopedic firm that was acquired by Johnson and Johnson in 2012. Mr. White is a member of the AOSpine and ISASS spine societies.

Previously, Mr. White was founder or CEO and board member of three start-up device firms, most recently Applied Spine, now doing business as Rachiotek. Prior to his start-up experiences, he was Senior Director of Business Development and Marketing at US Surgical Corporation where he was instrumental in rapidly growing the firm from $300 million to $1 billion as the highly acquisitive leader in the minimally invasive surgery segment. Mr. White also served as Vice President and General Manager, Surgery at Richard Allan Medical.  As a business development and chief executive, Mr. White has executed more than 60 deals valued in excess of $ 1 billion.

Mr. White holds a B.S. cum laude in Biology from Union College in Schenectady, N.Y. and resides outside of Philadelphia, PA.

Eric A. Stookey currently serves as the Chief Operating Officer of OsteoRemedies®, Memphis, TN, where he has helped guide the medical device organization focused on infection remedies, since joining in 2015.  Prior to joining OsteoRemedies®, Mr. Stookey served as the President of the Extremities-Biologics division at Wright Medical Group, Inc. (Nasdaq:WMGI) through 2014.  He served in various other marketing and sales positions at Wright Medical Group, Inc. since 1995, including the Senior Vice President and Chief Commercial Officer, Vice President North American Sales, Senior Director of Sales – Central Region, and Director of Marketing for Large Joint Reconstruction Products. He also worked for DePuy Orthopedics, Inc. from 1993 to 1995.

Mr. Stookey earned his Masters of Business-Administration degree from Christian Brothers University and his Bachelor of Science degree in Business from the Indiana University School of Business. He previously served as an independent board member for Cartiva, Inc., Alpharetta, GA, until the successful acquisition of the business by Wright Medical Group, Inc in 2018.

David W. Truetzel has approximately 20 years of experience in the financial services and technology industries in both a consultative and operating capacity. Mr. Truetzel is a General Partner of Augury Capital Partners, which he co-founded in 2006. He was a General Partner of Hela Capital Partners, a partnership focused on leveraged buyouts in the financial services industry, from 2001 through 2005. In addition, Mr. Truetzel was a Managing Director of Gryphon Investments II, a technology focused venture capital firm, from 2000 through 2003.. Mr. Truetzel sits on the Board of Directors of Enterprise Bank, Inc,  Elm Tree Funds II and Paranet, LLC.

Mr. Truetzel holds a B.S. in Accounting from Saint Louis University, an M.B.A. from The Wharton School and is a certified public accountant.

Eric A. Stookey currently serves as the Chief Operating Officer of OsteoRemedies®, Memphis, TN, where he has helped guide the medical device organization focused on infection remedies, since joining in 2015.  Prior to joining OsteoRemedies®, Mr. Stookey served as the President of the Extremities-Biologics division at Wright Medical Group, Inc. (Nasdaq:WMGI) through 2014.  He served in various other marketing and sales positions at Wright Medical Group, Inc. since 1995, including the Senior Vice President and Chief Commercial Officer, Vice President North American Sales, Senior Director of Sales – Central Region, and Director of Marketing for Large Joint Reconstruction Products. He also worked for DePuy Orthopedics, Inc. from 1993 to 1995.

Mr. Stookey earned his Masters of Business-Administration degree from Christian Brothers University and his Bachelor of Science degree in Business from the Indiana University School of Business. He previously served as an independent board member for Cartiva, Inc., Alpharetta, GA, until the successful acquisition of the business by Wright Medical Group, Inc in 2018.

David W. Truetzel has approximately 20 years of experience in the financial services and technology industries in both a consultative and operating capacity. Mr. Truetzel is a General Partner of Augury Capital Partners, which he co-founded in 2006. He was a General Partner of Hela Capital Partners, a partnership focused on leveraged buyouts in the financial services industry, from 2001 through 2005. In addition, Mr. Truetzel was a Managing Director of Gryphon Investments II, a technology focused venture capital firm, from 2000 through 2003.. Mr. Truetzel sits on the Board of Directors of Enterprise Bank, Inc,  Elm Tree Funds II and Paranet, LLC.

Mr. Truetzel holds a B.S. in Accounting from Saint Louis University, an M.B.A. from The Wharton School and is a certified public accountant.

Jeffrey White has operated in the surgical device and biomaterials industry for 35 years as a senior sales, marketing, business development and chief executive in Fortune 500, mid-size and start-up firms. Mr. White is currently Principal, Medtech Advisory Group LLC, a firm that advises early and mid-stage medtech firms. Most recently he was Vice President of Product Management at MiMedx, the leading placental allograft firm. Prior to that he was Global Director of Business Development for Synthes, a $4 billion global orthopedic firm that was acquired by Johnson and Johnson in 2012. Mr. White is a member of the AOSpine and ISASS spine societies.

Previously, Mr. White was founder or CEO and board member of three start-up device firms, most recently Applied Spine, now doing business as Rachiotek. Prior to his start-up experiences, he was Senior Director of Business Development and Marketing at US Surgical Corporation where he was instrumental in rapidly growing the firm from $300 million to $1 billion as the highly acquisitive leader in the minimally invasive surgery segment. Mr. White also served as Vice President and General Manager, Surgery at Richard Allan Medical.  As a business development and chief executive, Mr. White has executed more than 60 deals valued in excess of $ 1 billion.

Mr. White holds a B.S. cum laude in Biology from Union College in Schenectady, N.Y. and resides outside of Philadelphia, PA.